This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health Divests Unit to Focus on Core Business
by Zacks Equity Research
Community Health (CYH) completes the pending sale of 238-bed AllianceHealth Deaconess hospital to lower debts and concentrate more on core business.
DXC Expands Services Portfolio With Buyout of Argodesign
by Zacks Equity Research
DXC's acquisition of Argodesign not only adds product designing services to its portfolio, but also will aid in accelerating the digital transformation journey of its clients.
Employer Sponsored Health Insurance Premiums Jump: 4 Picks
by Ritujay Ghosh
An increasing number of memberships, with unemployment rate hitting a record low, have been one of the prime factors behind the top-line growth of the health insurance sector.
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
Community Health's (CYH) Ratings Downgraded, Outlook Stable
by Zacks Equity Research
Moody's Investors Service downgrades Community Health's (CYH) ratings. Outlook for the same is stable.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio (revised)
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
7 Solid Reasons to Add UnitedHealth (UNH) to Your Portfolio
by Zacks Equity Research
Banking on robust revenues, a bullish 2018 view, strong Optum segment and membership growth, UnitedHealth (UNH) shows great prospects to generate high returns for investors.
6 Reasons to Invest in WellCare Health for Portfolio Boost
by Zacks Equity Research
Banking on strong financial position, inorganic growth and a solid top-line improvement, WellCare Health (WCG) possesses great potential to generate high returns for investors.
Molina (MOH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
by Zacks Equity Research
Zacks.com featured highlights include: Conduent, Medifast, Commvault, Molina and Fortinet
5 Best-Ranked Liquid Stocks for Impressive Returns
by Zacks Equity Research
Here are five marvelous liquid stocks that investors should snap up now for stellar returns.
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY
4 Keys to the Bull Charging Ahead
by John Blank
A old bull market is not a dead bull market.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
MEDNAX (MD) Unveils Unit for Better Pediatric Hearing Care
by Zacks Equity Research
MEDNAX (MD) opens the doors of MEDNAX Audiology Institute to offer better hearing loss treatment for infants.
Anthem's (ANTM) Units Receive Rating Action From A.M. Best
by Zacks Equity Research
Credit rating agency A.M. Best affirms the ratings of Anthem's (ANTM) units. The outlook remains stable.
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet
Molina (MOH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Four Keys to the U.S. Bull Market: Zacks SEPT Market Strategy
by John Blank
Zacks Chief Strategist John Blank provides four key points to all traders and investors in U.S. stocks this fall.
Bet on These 5 Top Liquid Stocks for Stellar Returns
by Zacks Equity Research
Five top-ranked liquid stocks that are poised to offer marvelous returns.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina Healthcare Surges 80% YTD: Can the Rally Continue?
by Zacks Equity Research
Molina Healthcare (MOH) gains from its rebounding endeavors and a niche positioning in the Medicaid market.
Molina (MOH) Up 13.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Ideas feature highlights: HCA, WellCare and Molina
by Zacks Equity Research
Zacks Investment Ideas feature highlights: HCA, WellCare and Molina
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNY